공지사항

Antimicrobial

Agent

Organism

Interpretive Categories and MIC Breakpoints (㎍/mL)

변경전

CLSI 변경후

S

I

R

S

I

R

Oxacillin

Staphylococcus spp.,

except,

S. aureus and

S. lugdunensis

≤0.25

-

≥0.5

≤0.5

-

≥1

Gentamicin

Enterobacterales

≤ 4

8

≥ 16

≤ 2

4

≥ 8

Tobramycin

≤ 4

8

≥ 16

≤ 2

4

≥ 8

Amikacin

≤ 16

32

≥ 64

≤ 4

8

≥ 16

Cefazolin

≤ 8

16

≥ 32

≤ 4

-

≥ 8

Piperacillin

Pseudomonas aeruginosa

≤ 16

32-64

≥ 128

≤ 16

32

≥ 64

Piperacillin/

tazobactam

≤ 16/4

32/4-64/4

≥ 128/4

≤ 16/4

32/4

≥ 64/4

Tobramycin

≤ 4

8

≥ 16

≤ 1

2

≥ 4

Antimicrobial

Agent

Organism

Interpretive Categories and MIC Breakpoints (㎍/mL)

변경전

CLSI 변경후

S

I

R

S

SDD

R

Piperacillin/

tazobactam

Enterobacterales

≤ 16/4

32/4-64/4

≥ 128/4

≤ 8/4

16/4

≥ 32/4